Harvest Investment Services, LLC Ligand Pharmaceuticals Inc Transaction History

Harvest Investment Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$96.94 - $113.59 $366,820 - $429,824	-3,784 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$86.25 - $120.16 $112,383 - $156,568	-1,303 Reduced 25.61%	3,784 $368,000
Q2 2019 Jul 17, 2019	SELL	$107.38 - $129.34 $29,851 - $35,956	-278 Reduced 5.18%	5,087 $584,000
Q1 2019 Apr 17, 2019	BUY	$105.93 - $142.47 $568,314 - $764,351	5,365 New	5,365 $665,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.